Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Myovant Sciences Ltd.

http://myovant.com/

Latest From Myovant Sciences Ltd.

Napabucasin Failure Costly, And Possibly Transformative, For Dainippon

Japanese firm’s recent decision to halt development of its lead oncology asset, gained through a multi-billion-dollar acquisition where it was the main attraction, not only has a financial cost but may prompt more strategic deal-making.

Commercial Deals

Big Pharma Holds Steady With One-Third Of Novel Agents Approved In US In 2020

Gilead and Roche ended the year involved in three novel agents apiece, thanks to a combination of internal research and external licensing.

Approvals Companies

Big Pharma Holds Steady With One-Third Of Novel Agents Approved In US In 2020

Gilead and Roche ended the year involved in three novel agents apiece, thanks to a combination of internal research and external licensing. 

Approvals Companies

US FDA’s Three Review Speeds: Standard, Priority – And Oncology

FDA’s oncology review team likes to do things its own way – and at its own hyper fast pace.

Cancer Pink Sheet Perspectives
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
  • Other Names / Subsidiaries
    • Myovant Sciences GmbH
    • Myovant Sciences, Inc.
UsernamePublicRestriction

Register